The Cost-Effectiveness Of Canagliflozin Verse Liraglutide In Patients With Type 2 Diabetes (T2dm) Failing To Achieve Glycaemic Control On Metformin Monotherapy In Ireland
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.700
https://www.valueinhealthjournal.com/article/S1098-3015(14)02630-8/fulltext
Title :
The Cost-Effectiveness Of Canagliflozin Verse Liraglutide In Patients With Type 2 Diabetes (T2dm) Failing To Achieve Glycaemic Control On Metformin Monotherapy In Ireland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02630-8&doi=10.1016/j.jval.2014.08.700
First page :
A345
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
124